GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis
(MedPage Today) -- Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...
(MedPage Today) -- Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...
(MedPage Today) -- Among U.S. adults with diabetes and steatotic liver disease in the All of Us cohort, new use ...
Ageing is not a disease: it is a phase of life marked by many layered conditions that unfold across years ...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for ...
(MedPage Today) -- European nations may be winning at optimizing care for people with axial spondyloarthritis (axSpA), international survey data ...
(MedPage Today) -- A case report review examined complications, diagnosis, and treatment of genital Crohn's disease, a rare extraintestinal manifestation ...
This specialised technique is typically recommended for patients with a space-occupying lesion or tumour near the brain’s eloquent areas—regions responsible ...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for ...
Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic ...
A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.